FDA
-
-
-
-
-
-
-
Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms
-
-
-
-
-
-
-
Kane Biotech Restarts Commercial Activities and Strengthens North American Management
-
-
-
-
-
-
-
Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray
-
-
-
-
-
-
-
Kane Biotech Announces Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Kane Biotech Announces Second Quarter 2023 Financial Results
-
-
-
-
-
-
-
Kane Biotech Announces 510(k) Submission for its coactiv+™ Antimicrobial Hydrogel
-
-
-
-
-
-
-
Kane Biotech to Showcase Technologies and Products at the 2018 BIO International Convention
328,607 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

